HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial Cancers
CONCLUSIONS: HER2 GPA can be used to accurately determine HER2 status in endometrial cancers and is a highly valuable tool for identifying HER2 heterogeneity.PMID:36857635 | DOI:10.1093/ajcp/aqac179
Source: American Journal of Clinical Pathology - Category: Pathology Authors: Saba Shafi Hiroaki Nitta Manan Shah Bindu Challa Anil V Parwani Zaibo Li Source Type: research
More News: Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinosarcoma | Endometrial Cancer | Epithelial Cancer | Genetics | HER2 | Mixed Epithelial Carcinoma | Pathology | Serous Carcinoma